Hosted on MSN2mon
Philip Morris stock rises on FDA's first nicotine pouch approvalInvesting.com -- Shares of Philip Morris International Inc. (NYSE:PM) rose 1% following the U.S. Food and Drug Administration's (FDA) authorization of 20 ZYN nicotine pouch products for marketing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback